Revascularization Therapy: Who, How & When?
Alik Farber, MD, MBA, FACS, DFSVS
Connie N. Hess, MD, MHS
PAD Stage, Risk Assessment & Comorbidities
Guidelines on the Management of Patients with PAD
Marc P. Bonaca, MD, MPH
Naomi Hamburg, MD, MS
Schuyler Jones, MD
Manesh R. Patel, MD
Medical Therapy: New Horizons of Diabetic Therapies
Overcoming Disparities of Care - Impact of Social Determinants of Health of PAD
Medical Therapy: Lipid Modifying Therapies
Medical Therapy: Antithrombotic Management of PAD—What Has Changed?
Are the current guidelines current?
Vallerie V. McLaughlin, MD
Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification
Ioana Preston, MD
Risk Stratification Refinements with inclusion of Hemodynamic variables at follow up in patients with PH
Richard N. Channick, MD
The Next Generation of Treatment for Patients With PH
Strategies to Implement Risk Stratification in the PH Clinic
The Promise of Sotatercept in PAH
Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension
Integrating Evidence for Improved Outcomes in PH
Kelly Chin, MD, MSCA
Richard Krasuski, MD
Update in Pediatric Pulmonary Hypertension
Loading...
We're glad to see you're enjoying MedEd On The Go… but how about a more personalized experience?
Press cancel to remain on MedEd On The Go. Press the link below or the continue button to keep going.